$1,680,000 of BANK OF AMERICA CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 7548, SCAM Act; provisions related to cybercrime and fraud. S. 875, FIRM Act; provisions related to regulatory capital and liquidity. S. 2999, Main Street Depositor Protection Act; provisions related to deposit insurance reform. S. 4198, Main Street Depositor Protection Act; provisions related to deposit insurance reform. PL 119-21, One Big Beautiful Bill Act; implementation of renewable energy tax credit and foreign entity rules. Issues related to Trump Accounts. Issues related to taxation of digital assets. H.R. 2392, STABLE Act of 2025; provisions related to digital assets and stablecoins. H.R. 3633, Digital Asset Market Clarity Act of 2025; provisions related to digital assets and stablecoin. PL 119-27, GENIUS Act; implementation of payment of interest provisions. Issues related to SEC regulatory proposals on market structure. Issues related to federal preemption standard for financial institutions. Issues related to AML reform."
You can find more data on corporate lobbying on Quiver Quantitative.
BAC Congressional Stock Trading
Members of Congress have traded $BAC stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $BAC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BAC Insider Trading Activity
BAC insiders have traded $BAC stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $BAC stock by insiders over the last 6 months:
- DEAN C ATHANASIA (Co-President) sold 136,558 shares for an estimated $6,856,167
- BERNARD A MENSAH (President, International) sold 94,000 shares for an estimated $4,412,642
- JAMES P DEMARE (Co-President) sold 83,832 shares for an estimated $4,191,600
- ALASTAIR M BORTHWICK (Executive Vice President & CFO) sold 68,000 shares for an estimated $3,416,320
- SHERI B. BRONSTEIN (Chief People Officer) sold 60,000 shares for an estimated $2,994,600
- THOMAS M SCRIVENER (Chief Operations Executive) sold 50,000 shares for an estimated $2,491,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BAC Hedge Fund Activity
We have seen 1,612 institutional investors add shares of BAC stock to their portfolio, and 1,493 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 142,443,052 shares (-76.6%) from their portfolio in Q4 2025, for an estimated $7,834,367,860
- BERKSHIRE HATHAWAY INC removed 50,774,078 shares (-8.9%) from their portfolio in Q4 2025, for an estimated $2,792,574,290
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 44,413,993 shares (+7091.3%) to their portfolio in Q4 2025, for an estimated $2,442,769,615
- CAPITAL INTERNATIONAL INVESTORS added 42,862,620 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,357,444,100
- CITIGROUP INC removed 29,298,493 shares (-54.9%) from their portfolio in Q4 2025, for an estimated $1,611,417,115
- VANGUARD GROUP INC added 23,351,183 shares (+3.7%) to their portfolio in Q4 2025, for an estimated $1,284,315,065
- CARDANO RISK MANAGEMENT B.V. removed 22,441,091 shares (-89.4%) from their portfolio in Q1 2026, for an estimated $1,073,985,733
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BAC Analyst Ratings
Wall Street analysts have issued reports on $BAC in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 01/15/2026
- Truist Securities issued a "Buy" rating on 01/15/2026
- TD Cowen issued a "Buy" rating on 01/15/2026
- CICC issued a "Outperform" rating on 01/14/2026
- Goldman Sachs issued a "Buy" rating on 01/06/2026
- Barclays issued a "Overweight" rating on 01/05/2026
- Oppenheimer issued a "Outperform" rating on 11/19/2025
To track analyst ratings and price targets for BAC, check out Quiver Quantitative's $BAC forecast page.
BAC Price Targets
Multiple analysts have issued price targets for $BAC recently. We have seen 15 analysts offer price targets for $BAC in the last 6 months, with a median target of $61.0.
Here are some recent targets:
- Chris Mcgratty from Keefe, Bruyette & Woods set a target price of $64.0 on 04/16/2026
- Glenn Schorr from Evercore ISI Group set a target price of $61.0 on 04/16/2026
- John McDonald from Truist Securities set a target price of $61.0 on 04/16/2026
- Scott Siefers from Piper Sandler set a target price of $59.0 on 04/16/2026
- Chris Kotowski from Oppenheimer set a target price of $61.0 on 04/16/2026
- Gerard Cassidy from RBC Capital set a target price of $59.0 on 04/16/2026
- Vivek Juneja from JP Morgan set a target price of $57.5 on 04/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
